Literature DB >> 2575601

The gastroenteropancreatic endocrine system and related tumors.

E Solcia1, C Capella, R Fiocca, M Cornaggia, F Bosi.   

Abstract

Up to 16 types of endocrine cells have been characterized morphologically (and most of them also functionally) in the gastroenteropancreatic area. Four main groups of pancreatic endocrine tumors (with several subtypes) have been identified: islet cell, ectopic, nonfunctioning, and poorly differentiated tumors. A detailed classification system that combines cytologic and clinicopathologic patterns has been developed for the study of 132 pancreatic tumors. Among a large series (more than 120 cases) of endocrine tumors arising in the gastrointestinal tract, serotonin-producing argentaffin carcinoids have been separated from hindgut trabecular carcinoids, producing glucagon- and pancreatic polypeptide-related peptides, paragangliomas, somatostatin cell tumors, gastrinomas, and argyrophil ECL cell carcinoids. The clinicopathologic profile of the various pancreatic and gastrointestinal tumor entities has been delineated and involvement in the multiple endocrine neoplasia syndrome has been analyzed in detail.

Entities:  

Mesh:

Year:  1989        PMID: 2575601

Source DB:  PubMed          Journal:  Gastroenterol Clin North Am        ISSN: 0889-8553            Impact factor:   3.806


  17 in total

Review 1.  Unresolved surgical issues in the management of patients with Zollinger-Ellison syndrome.

Authors:  J A Norton; R T Jensen
Journal:  World J Surg       Date:  1991 Jan-Feb       Impact factor: 3.352

2.  Histopathology, hormone products, and clinicopathological profile of endocrine tumors of the upper small intestine: A study of 44 cases.

Authors:  Carlo Capella; Cristina Riva; Guido Rindi; Fausto Sessa; Luciana Usellini; Annamaria Chiaravalli; Luciano Carnevali; Enrico Solcia
Journal:  Endocr Pathol       Date:  1991-06       Impact factor: 3.943

3.  Successful and unsuccessful approaches to imaging carcinoids: comparison of a radiolabelled tryptophan hydroxylase inhibitor with a tracer of biogenic amine uptake and storage, and a somatostatin analogue.

Authors:  D Macfarlane; J Gonin; D Wieland; T Mangner; J Froelich; W Beierwaltes; B Shapiro
Journal:  Eur J Nucl Med       Date:  1996-02

4.  Clinical symptoms, hormone profiles, treatment, and prognosis in patients with gastric carcinoids.

Authors:  D Granberg; E Wilander; M Stridsberg; G Granerus; B Skogseid; K Oberg
Journal:  Gut       Date:  1998-08       Impact factor: 23.059

Review 5.  Use of omeprazole in patients with Zollinger-Ellison syndrome.

Authors:  H Frucht; P N Maton; R T Jensen
Journal:  Dig Dis Sci       Date:  1991-04       Impact factor: 3.199

6.  Site-specific epithelial-mesenchymal interactions in digestive neuroendocrine tumors. An experimental in vivo and in vitro study.

Authors:  J Dumortier; C Ratineau; J Y Scoazec; C Pourreyron; W Anderson; M F Jacquier; M Blanc; C Bernard; C Bellaton; L Remy; J A Chayvialle; C Roche
Journal:  Am J Pathol       Date:  2000-02       Impact factor: 4.307

Review 7.  Current approach to the management of gastrinoma and insulinoma in adults with multiple endocrine neoplasia type I.

Authors:  M Mignon; P Ruszniewski; P Podevin; L Sabbagh; G Cadiot; D Rigaud; S Bonfils
Journal:  World J Surg       Date:  1993 Jul-Aug       Impact factor: 3.352

8.  Curative resection in Zollinger-Ellison syndrome. Results of a 10-year prospective study.

Authors:  J A Norton; J L Doppman; R T Jensen
Journal:  Ann Surg       Date:  1992-01       Impact factor: 12.969

9.  Nuclear DNA content in 27 pancreatic endocrine tumours: correlation with malignancy, survival and expression of glycoprotein hormone alpha chain.

Authors:  C Donow; H Baisch; P U Heitz; G Klöppel
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

10.  Gastrin receptor genes are expressed in gastric parietal and enterochromaffin-like cells of Mastomys natalensis.

Authors:  M Asahara; Y Kinoshita; H Nakata; Y Matsushima; Y Naribayashi; A Nakamura; T Matsui; K Chihara; J Yamamoto; A Ichikawa
Journal:  Dig Dis Sci       Date:  1994-10       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.